How Will Walgreen (WAG) Stock React to Possible Sale of Infusion Business?

NEW YORK (TheStreet) -- Walgreen Co. (WAG) , the drugstore chain operator, is considering the sale of a majority stake in its infusion services business, in a deal that could value that division at about $1.5 billion, sources told Reuters.

The company has hired Bank of America (BAC)  to run a sale process for Walgreens Infusion Services, which has already attracted interest from private equity firms, sources added.

On offer is a controlling stake of just over 50% in Walgreens Infusion Services, which has annual earnings before interest, tax, depreciation and amortization of around $105 million, sources told Reuters.

 

Shares of Walgreen are slightly lower in pre-market trade. 

WAG Chart WAG data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

This Year's Flu Season Is Out of Control

This Year's Flu Season Is Out of Control

Best of Stocks, Worst of Stocks: Cramer's 'Mad Money' Recap (Monday 10/30/17)

Best of Stocks, Worst of Stocks: Cramer's 'Mad Money' Recap (Monday 10/30/17)

Bearish Signals for Consumer Staples: Cramer's 'Off the Charts'

Bearish Signals for Consumer Staples: Cramer's 'Off the Charts'

Cramer: Supply in Retail and Financials, Demand in Tech

Cramer: Supply in Retail and Financials, Demand in Tech

Cramer: Dominoes Are in Play Today

Cramer: Dominoes Are in Play Today